Clinical Trial Update: IKS014 in Advanced Solid Tumors That Express HER2 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of IKS014 for HER2-expressing advanced solid tumors is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Gastric Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• IKS014

Snippet

Sponsor: Iksuda Therapeutics Ltd. | Conditions: Breast Cancer, Gastric Cancer | Phase 1 | Status: RECRUITING